Gujarat Themis Biosyn Ltd
19 Nov 2024 12:00 AM
Board approved merger of Gujarat Themis Biosyn with Themis Medicare,
The Board of Directors of Gujarat Themis Biosyn (GTBL) and Themis Medicare (TML) have approved a Scheme of Amalgamation of Gujarat Themis Biosyn with Themis Medicare. The Scheme is subject to approval of the secured creditors and shareholders of TML and GTBL, the stock exchanges, SEBI, NCLT and other regulatory approvals as may be required. This amalgamation will result in consolidation of businesses and integration of the entire product value chain under a single amalgamated entity, leading to significant synergies.Under the scheme, TML will issue and allot 118 equity shares of the face value of Re. 1 each, credited as fully paid-up, for every 100 equity shares of the face value of Re. 1 each fully paid-up, held by shareholders in GTBL.Powered by Capital Market - Live News
Gujarat Themis Biosyn Ltd
25 Oct 2024 12:00 AM
Gujarat Themis Biosyn standalone net profit declines 15.71% in the September 2024 quarter,
Net profit of Gujarat Themis Biosyn declined 15.71% to Rs 10.57 crore in the quarter ended September 2024 as against Rs 12.54 crore during the previous quarter ended September 2023. Sales declined 12.19% to Rs 34.72 crore in the quarter ended September 2024 as against Rs 39.54 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales34.7239.54 -12 OPM %44.3542.26 - PBDT15.6417.76 -12 PBT14.2016.88 -16 NP10.5712.54 -16 Powered by Capital Market - Live News
Gujarat Themis Biosyn Ltd
19 Oct 2024 12:00 AM
Gujarat Themis Biosyn schedules board meeting,
Gujarat Themis Biosyn will hold a meeting of the Board of Directors of the Company on 25 October 2024.Powered by Capital Market - Live News
Gujarat Themis Biosyn Ltd
26 Jul 2024 12:00 AM
Gujarat Themis Biosyn standalone net profit declines 25.28% in the June 2024 quarter,
Net profit of Gujarat Themis Biosyn declined 25.28% to Rs 13.24 crore in the quarter ended June 2024 as against Rs 17.72 crore during the previous quarter ended June 2023. Sales declined 21.70% to Rs 38.83 crore in the quarter ended June 2024 as against Rs 49.59 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales38.8349.59 -22 OPM %47.8047.43 - PBDT19.0124.56 -23 PBT17.8623.81 -25 NP13.2417.72 -25 Powered by Capital Market - Live News
Gujarat Themis Biosyn Ltd
17 Jul 2024 12:00 AM
Gujarat Themis Biosyn schedules board meeting,
Gujarat Themis Biosyn will hold a meeting of the Board of Directors of the Company on 26 July 2024.Powered by Capital Market - Live News
Subscribe for our
newsletter
newsletter